Richard Pietras to Treatment Outcome
This is a "connection" page, showing publications Richard Pietras has written about Treatment Outcome.
Connection Strength
0.137
-
Randomized phase II study of fulvestrant and erlotinib compared with erlotinib alone in patients with advanced or metastatic non-small cell lung cancer. Lung Cancer. 2018 09; 123:91-98.
Score: 0.129
-
Inhibitory effects of combinations of HER-2/neu antibody and chemotherapeutic agents used for treatment of human breast cancers. Oncogene. 1999 Apr 01; 18(13):2241-51.
Score: 0.009